Alzheimer's disease (AD) is a prevalently found tauopathy characterized by memory loss
and cognitive insufficiency. AD is an age-related neurodegenerative disease with two major …

Alzheimer's disease (AD) is one of the serious and progressive neurodegenerative
disorders in the elderly worldwide. Various genetic, environmental, and lifestyle factors are …

The rapid and direct detection of biomarkers in biofluids at clinically relevant concentrations
faces serious limitations to develop diagnostic criteria for neurodegenerative diseases such …

Alzheimer disease (AD) is the most prominent form of dementia and the 5th leading cause of
death in individuals over 65. AD is a complex disease stemming from genetic …

Quinazolines are considered as a promising class of bioactive heterocyclic compounds with
broad properties. Particularly, the quinazoline scaffold has an impressive role in the design …

Amyloid beta peptide is an important biomarker in Alzheimer's disease, with the
amyloidogenic hypothesis as one of the central hypotheses trying to explain this type of …

Alzheimer's disease (AD) has become increasingly prevalent in the elderly population
across the world. It's pathophysiological markers such as overproduction along with the …

Globally, Alzheimer's disease (AD) is one of the most prevalent age-related
neurodegenerative disorders associated with cognitive decline and memory deficits due to …

Background Amyloid β peptide (Aβ) is involved in osteoporosis, but the effects of Aβ on
osteoblast and bone formation remain unclear. In this study, we investigated the effect of Aβ …

Neurodegenerative diseases are progressive diseases of the nervous system that lead to
neuron loss or functional disorders. Neurodegenerative diseases require long-term …